MBRX - Moleculin Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development4,5451,496625.003
Selling General and Administrative4,0902,3811,146.744
Non Recurring---
Others---
Total Operating Expenses8,6533,8831,771.747
Operating Income or Loss-8,653-3,883-1,771.747
Income from Continuing Operations
Total Other Income/Expenses Net-1,152-43-24.317
Earnings Before Interest and Taxes-8,653-3,883-1,771.747
Interest Expense--43-24.317
Income Before Tax-9,805-3,926-1,796.064
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-9,805-3,926-1,796.064
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-9,805-3,926-1,796.064
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-9,805-3,926-1,796.064